Menopause

‘They’re not just safe, but there’s harm in not using these creams. Women can die from not using them.’

A review of new launches, new indications, new dosage forms and Health Canada advisories.

Health Canada extends the time period for use of a single Mirena intrauterine system for conception control from five years to eight years.

They reduce cancer mortality risk but increase risk for CVD death.

There is always a place for the pharmacist as a generalist, as the most accessible health professional. It is an asset when members of any pharmacy team, community or otherwise, take on areas of focus in their learning to support each other.

Over the years I have observed increased interest in learning more about topics like gut health and women’s’ health. I am very proud of my colleagues; they have been leaders and very proactive in educating patients and other healthcare professionals in both areas.

Knight Therapeutics launches Imvexxy (estradiol vaginal inserts) for postmenopausal dyspareunia and Bijuva (estradiol/progesterone capsules) for menopausal vasomotor symptoms.

A look at the many preconceptions (and their related products) your patients may have about menopause.